These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 2573416)
1. Multidrug resistance in a human leukemic cell line selected for resistance to trimetrexate. Arkin H; Ohnuma T; Kamen BA; Holland JF; Vallabhajosula S Cancer Res; 1989 Dec; 49(23):6556-61. PubMed ID: 2573416 [TBL] [Abstract][Full Text] [Related]
2. N10-propargyl-5,8-dideazafolic acid (CB3717): inhibitory effects on human leukemia cell lines resistant to methotrexate or trimetrexate. Takemura Y; Ohnuma T Mt Sinai J Med; 1992 Oct; 59(5):419-24. PubMed ID: 1435841 [TBL] [Abstract][Full Text] [Related]
3. Protein kinase C activity and multidrug resistance in MOLT-3 human lymphoblastic leukemia cells resistant to trimetrexate. Schwartz GK; Arkin H; Holland JF; Ohnuma T Cancer Res; 1991 Jan; 51(1):55-61. PubMed ID: 1824824 [TBL] [Abstract][Full Text] [Related]
4. Patterns of cross-resistance to the antifolate drugs trimetrexate, metoprine, homofolate, and CB3717 in human lymphoma and osteosarcoma cells resistant to methotrexate. Diddens H; Niethammer D; Jackson RC Cancer Res; 1983 Nov; 43(11):5286-92. PubMed ID: 6225514 [TBL] [Abstract][Full Text] [Related]
5. Mechanism of acquired resistance to methotrexate in P388 murine leukemia cells and in their doxorubicin-resistant subline. Ramu N; Ramu A; Cole DE; Balis FM; Poplack DG; Pollard HB Isr J Med Sci; 1988; 24(9-10):477-82. PubMed ID: 2974448 [TBL] [Abstract][Full Text] [Related]
6. A phenotype conferring selective resistance to lipophilic antifolates in Chinese hamster ovary cells. Sharma RC; Assaraf YG; Schimke RT Cancer Res; 1991 Jun; 51(11):2949-59. PubMed ID: 1674447 [TBL] [Abstract][Full Text] [Related]
7. Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells. Yusa K; Tsuruo T Cancer Res; 1989 Sep; 49(18):5002-6. PubMed ID: 2569930 [TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity of trimetrexate against antifolate-resistant human T-cell leukemia cell lines developed in oxidized or reduced folate. Miyachi H; Takemura Y; Kobayashi H; Ando Y Jpn J Cancer Res; 1997 Sep; 88(9):900-6. PubMed ID: 9369939 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological and biological evidence for differing mechanisms of doxorubicin resistance in two human tumor cell lines. Slovak ML; Hoeltge GA; Dalton WS; Trent JM Cancer Res; 1988 May; 48(10):2793-7. PubMed ID: 2896069 [TBL] [Abstract][Full Text] [Related]
10. A human leukemia cell line made resistant to two folate analogues, trimetrexate and N10-propargyl-5,8-dideazafolic acid (CB3717). Takemura Y; Ohnuma T; Miyachi H; Sekiguchi S J Cancer Res Clin Oncol; 1991; 117(6):519-25. PubMed ID: 1683871 [TBL] [Abstract][Full Text] [Related]
11. Establishment of methotrexate-resistant human acute lymphoblastic leukemia cells in culture and effects of folate antagonists. Ohnoshi T; Ohnuma T; Takahashi I; Scanlon K; Kamen BA; Holland JF Cancer Res; 1982 May; 42(5):1655-60. PubMed ID: 6978176 [TBL] [Abstract][Full Text] [Related]
12. Reduced intracellular drug accumulation in the absence of P-glycoprotein (mdr1) overexpression in mitoxantrone-resistant human MCF-7 breast cancer cells. Nakagawa M; Schneider E; Dixon KH; Horton J; Kelley K; Morrow C; Cowan KH Cancer Res; 1992 Nov; 52(22):6175-81. PubMed ID: 1358431 [TBL] [Abstract][Full Text] [Related]
13. Flow cytometric characterization of antifolate resistance in cultured mammalian cells using fluoresceinated methotrexate and daunorubicin. Sherwood SW; Assaraf YG; Molina A; Schimke RT Cancer Res; 1990 Aug; 50(16):4946-50. PubMed ID: 2143099 [TBL] [Abstract][Full Text] [Related]
14. Cytogenetic and phenotypic analysis of a human colon carcinoma cell line resistant to mitoxantrone. Dalton WS; Cress AE; Alberts DS; Trent JM Cancer Res; 1988 Apr; 48(7):1882-8. PubMed ID: 2894893 [TBL] [Abstract][Full Text] [Related]
15. Role of differential drug uptake, efflux, and binding of etoposide in sensitive and resistant human tumor cell lines: implications for the mechanisms of drug resistance. Politi PM; Sinha BK Mol Pharmacol; 1989 Mar; 35(3):271-8. PubMed ID: 2564628 [TBL] [Abstract][Full Text] [Related]
16. Expression of variant dihydrofolate reductase with decreased binding affinity to antifolates in MOLT-3 human leukemia cell lines resistant to trimetrexate. Miyachi H; Takemura Y; Kobayashi H; Ando Y Cancer Lett; 1995 Jan; 88(1):93-9. PubMed ID: 7850779 [TBL] [Abstract][Full Text] [Related]
17. Effect of duration of exposure to verapamil on vincristine activity against multidrug-resistant human leukemic cell lines. Cass CE; Janowska-Wieczorek A; Lynch MA; Sheinin H; Hindenburg AA; Beck WT Cancer Res; 1989 Nov; 49(21):5798-804. PubMed ID: 2790792 [TBL] [Abstract][Full Text] [Related]
18. Atypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein. Haber M; Norris MD; Kavallaris M; Bell DR; Davey RA; White L; Stewart BW Cancer Res; 1989 Oct; 49(19):5281-7. PubMed ID: 2569932 [TBL] [Abstract][Full Text] [Related]
19. Multidrug resistance in mitoxantrone-selected HL-60 leukemia cells in the absence of P-glycoprotein overexpression. Harker WG; Slade DL; Dalton WS; Meltzer PS; Trent JM Cancer Res; 1989 Aug; 49(16):4542-9. PubMed ID: 2568172 [TBL] [Abstract][Full Text] [Related]
20. Sequential emergence of distinct resistance phenotypes in murine erythroleukemia cells under adriamycin selection: decreased anthracycline uptake precedes increased P-glycoprotein expression. Slapak CA; Daniel JC; Levy SB Cancer Res; 1990 Dec; 50(24):7895-901. PubMed ID: 1979251 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]